Skip to content

Press Release

Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-Based Therapeutics and In Vivo Reprogramming

Written by CoMotion Staff / July 12, 2023
This press release is in an external website. Please click the button below to go to the site.